Is it time to miss the target for prostate cancer?

BJU Int. 2012 Feb;109(4):492-3. doi: 10.1111/j.1464-410X.2011.10857.x.
No abstract available

MeSH terms

  • Critical Pathways*
  • Humans
  • Male
  • Prostatic Neoplasms / therapy*
  • Referral and Consultation
  • Time Factors
  • Watchful Waiting